Covered recipient · General Payments record
GAURAV AGNIHOTRI
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2022–2024
$2,483.32
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,066.46 | 9 |
| Education | $94.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Scientific Affairs, LLC | $295.87 | 2 |
| Janssen Biotech, Inc. | $225.00 | 2 |
| Incyte Corporation | $169.87 | 2 |
| GENZYME CORPORATION | $135.98 | 1 |
| ABBVIE INC. | $122.91 | 1 |
| Lilly USA, LLC | $113.41 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $122.91 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103181240 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.41 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117997015 | CMS |
| GENZYME CORPORATION | $135.98 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140001577 | CMS |
| Incyte Corporation | $114.69 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141197853 | CMS |
| Incyte Corporation | $55.18 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141274530 | CMS |
| Janssen Biotech, Inc. | $130.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078575780 | CMS |
| Janssen Biotech, Inc. | $94.99 | 06/19/2024 | Education | Undisputed | 01/23/2026 | 1078579852 | CMS |
| Janssen Scientific Affairs, LLC | $148.24 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078849625 | CMS |
| Janssen Scientific Affairs, LLC | $147.63 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078849587 | CMS |
| Lilly USA, LLC | $113.41 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134983586 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.